BioAge Labs (BIOA) Free Cash Flow (2023 - 2026)

BioAge Labs has disclosed Free Cash Flow across 4 years of filings, most recently posting -$24.1 million for Q1 2026.

• Free Cash Flow for Q1 2026 came in at -$24.1 million, down 35.32% year-over-year; the trailing twelve-month figure through Mar 2026 was -$88.6 million (down 64.11% YoY), and the FY2025 annual result was -$82.3 million, down 58.7% from the prior year.
• Free Cash Flow came in at -$24.1 million for Q1 2026 at BioAge Labs, up from -$28.4 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of -$5.2 million in Q4 2024 to a low of -$28.4 million in Q4 2025.
• The 4-year median for Free Cash Flow is -$15.9 million (2024), against an average of -$16.7 million.
• Across the five-year window, Free Cash Flow jumped 39.27% in 2024 and plunged 449.24% in 2025, its largest moves.
• BioAge Labs' Free Cash Flow stood at -$8.5 million in 2023, then surged by 39.27% to -$5.2 million in 2024, then slumped by 449.24% to -$28.4 million in 2025, then rose by 15.13% to -$24.1 million in 2026.
• The last three Free Cash Flow figures came in at -$24.1 million (Q1 2026), -$28.4 million (Q4 2025), and -$16.1 million (Q3 2025), per Business Quant data.